Early intervention for first episodes of schizophrenia: a preliminary exploration

scientific article published on February 1, 1992

Early intervention for first episodes of schizophrenia: a preliminary exploration is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/00332747.1992.11024572
P698PubMed publication ID1557469

P2093author name stringI. R. Falloon
P2860cites workIs schizophrenia disappearing?Q57403542
Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluationQ34285453
Stages of onset of schizophrenic psychosisQ40175491
Low dose fluphenazine decanoate in maintenance treatment of schizophreniaQ40298512
Prodromal symptoms in primary major depressive disorderQ48895154
Decreasing first-admission rates of schizophrenia among males in Denmark from 1970 to 1984. Changing diagnostic patterns?Q50548620
Psychophysiological dysfunctions in the developmental course of schizophrenic disorders.Q52276698
A comparative trial of pharmacologic strategies in schizophrenia.Q54132495
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
schizophrenic psychologyQ69941090
P304page(s)4-15
P577publication date1992-02-01
P1433published inPsychiatryQ15760563
P1476titleEarly intervention for first episodes of schizophrenia: a preliminary exploration
P478volume55

Reverse relations

cites work (P2860)
Q90752929'At risk mental state' clinics for psychosis - an idea whose time has come - and gone!
Q50698703A 'navigator' model in emerging mental illness?
Q78726349A decade of debate on early intervention in psychosis: a systematic review of screening criteria
Q33415727Adolescence and schizophrenia
Q38084211Antipsychotic interventions in prodromal psychosis: safety issues
Q40771364Can we improve the diagnostic efficiency and predictive power of prodromal symptoms for schizophrenia?
Q34701054Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial.
Q41376137Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101.
Q47429226Duration of untreated psychosis and its correlates in first-episode psychosis in Finland and Spain.
Q64095132Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
Q24243986Early Intervention for psychosis
Q24248672Early Intervention for psychosis
Q33948803Early detection and intervention in first-episode schizophrenia: a critical review
Q39460348Early intervention and evaluation for adult-onset psychosis: the JCEP study rationale and design.
Q24236296Early intervention for psychosis
Q22242332Early intervention in patients at ultra high risk of psychosis: benefits and risks
Q51950564Early intervention in schizophrenia: a critique.
Q34095720Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders
Q37075761Ethical concerns in schizophrenia research: looking back and moving forward
Q34085415Ethics and early intervention in psychosis: keeping up the pace and staying in step
Q38895381Family Interventions for Schizophrenia and the Psychoses: A Review
Q57738646Früherkennung und Frühintervention der Schizophrenie
Q33585800Improving outcome in schizophrenia: the case for early intervention
Q44984345Is a national framework for implementing early psychosis services necessary? Results of a survey of Australian mental health service directors
Q35102462Is earlier better? At the beginning of schizophrenia: timing and opportunities for early intervention
Q41817312Is pre-psychotic intervention of schizophrenia realistic ?
Q41712954Is pre-psychotic intervention realistic in schizophrenia and related disorders?
Q51967984Long delays in seeking treatment for schizophrenia.
Q36420469MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms
Q40954844New directions in the prevention and treatment of schizophrenia: a biological perspective
Q77482059New views on the course and treatment of schizophrenia
Q40578526PROD-screen--a screen for prodromal symptoms of psychosis.
Q33844294Portland identification and early referral: a community-based system for identifying and treating youths at high risk of psychosis
Q35847530Preferences for different insomnia treatment options in people with schizophrenia and related psychoses: a qualitative study
Q74292467Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis
Q36058891Prevention of schizophrenia: can it be achieved?
Q34776827Prevention of the first episode of psychosis
Q58410416Prodromal symptoms of schizophrenia in first-episode psychosis: Prevalence and specificity
Q51876670Prospective outcome of early intervention for individuals at ultra-high-risk for psychosis.
Q34322848Psychosis treatment prior to psychosis onset: ethical issues
Q40568751Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome
Q34322854Rationale for the study of early intervention
Q37979228Recent developments in family psychoeducation as an evidence-based practice
Q34203122Reduction in incidence of hospitalizations for psychotic episodes through early identification and intervention
Q51948707Self‐reported psychotic experiences in the general population: a valid screening tool for DSM‐III‐R psychotic disorders?
Q36688885Service Profile of Youths with Schizophrenia-Spectrum Diagnoses
Q35950862Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis
Q34061090Stress in schizophrenia: an integrative view
Q33881117Subthreshold symptoms and vulnerability indicators (e.g., eye tracking dysfunction) in schizophrenia
Q33788253Symptom assessment in schizophrenic prodromal states
Q90796885The DSM-5 proposal for attenuated psychosis syndrome: a history
Q39270119The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe
Q29542112The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis
Q57998248The Pace Clinic: Development of a Clinical Service for Young People at High Risk of Psychosis
Q34101213The continuity of psychotic experiences in the general population.
Q47811747The delaying effect of stigma on mental health help-seeking in Sri Lanka
Q52007219The initial prodrome in psychosis: descriptive and qualitative aspects.
Q38568466The introduction of an early warning signs journal in an adolescent inpatient unit
Q57998245The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey
Q52880770The reliability of DSM-III prodromal symptoms in first-episode psychotic patients.
Q38074729The ultra-high risk concept-a review.
Q34417104The varied outcomes of schizophrenia
Q35236583Treating early psychosis: who, what, and when?
Q71710406Treatment of schizophrenia
Q42072050Treatment timing vs treatment type in first-episode psychosis: a paradigm shift in strategy and effectiveness
Q34571739Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study
Q34113069Use of quantitative rating scales to assess outcome in schizophrenia prevention studies
Q40617995Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome
Q34742559Vulnerability to schizophrenia and psychotherapeutic treatment of schizophrenic patients: towards an integrated view
Q51560812Young people at risk of psychosis: a user-led exploration of interpersonal relationships and communication of psychological difficulties.

Search more.